´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ÀüÁ¦Ç°º¸±â > Stem Cell > hiPSC/hESC > [Àû¿ë] iPS cell reprogramming

[Àû¿ë] iPS cell reprogramming

-


human fibroblasts·ÎºÎÅÍ iPS cell line ±¸Ãà

PBMC reprogramming protocol¿¡ µû¶ó, Sendai virus¿Í Cellartis¢ç DEF-CS¢â system¸¦ ÀÌ¿ëÇÏ¿© 3¸íÀÇ donor·ÎºÎÅÍ È¹µæÇÑ human fibroblast¸¦ iPS cell·Î reprogramming ÇÑ ÈÄ, ¼¼Æ÷ÁÖ·Î ±¸ÃàÇÏ¿´´Ù (±×¸² 1).


±×¸² 1. Cellartis¢ç DEF-CS¢â systemÀ» ÀÌ¿ëÇÑ iPS cell reprogramming timeline

3¸íÀÇ donor (A-C)·ÎºÎÅÍ È¹µæÇÑ human fibroblast¸¦ ÀÌ¿ëÇÏ¿© reprogrammingÀ» ÁøÇàÇÏ¿´´Ù. °¢ donorº° human fibroblast 106°³¸¦ ÀÌ¿ëÇÏ¿© ¼øÂ÷ÀûÀ¸·Î ÇüÁú µµÀÔÇÏ¿´´Ù. À̸¦ ÅëÇØ ¸¹Àº ¼öÀÇ colony¸¦ ȹµæÇÏ¿´À¸¸ç, Ãß°¡ ¹è¾çÀ» À§ÇØ °¢ donorº°·Î 37-49°³ÀÇ colony¸¦ ¼±º°ÇÏ¿© ¾ÈÁ¤ÀûÀ¸·Î iPS cellÀ» ±¸ÃàÇÒ ¼ö ÀÖ¾ú´Ù. Donor¿¡ µû¶ó colony »ýÁ¸À²Àº 33-65%·Î ´Ù¾çÇÏ°Ô È®ÀεǾúÀ¸¸ç, ÀÌ ¶§ »ýÁ¸À²Àº pluripotency¿Í ¼ºÀ强À» Áö´Ï´Â colony¸¦ ÀǹÌÇÑ´Ù (Ç¥ 1).

Donor

A

B

C

Picked colonies

15

12

12

Generated iPS cell lines

6

9

8

Generated iPS cell lines (%)

40

75

67

Ç¥ 1. °¢ donorÀÇ ¼±º° colony »ýÁ¸À²

°¢ ´Ü°è¿¡¼­ ¼¼Æ÷ÀÇ ÇüÅÂÇÐÀû °üÂûÀ» ÁøÇàÇÏ¿´´Ù. Colony¸¦ ¼±º°ÇÑ ÈÄ, ÇüÅÂÇÐÀû º¯È­¸¦ È®ÀÎÇÏ¿´°í, ¹è¾ç 22ÀÏÂ÷ÀÇ Passage 6¿¡¼­ ¼¼Æ÷¸¦ µ¿°áÇÏ¿© º¸°üÇÒ ¼ö ÀÖÀ» Á¤µµ·Î ¾ÈÁ¤È­ µÇ¾ú´Ù (±×¸² 2).


±×¸² 2. Colony¸¦ ¼±º°ÇÑ ÈÄ ¾ÈÁ¤È­ µÇ±â±îÁöÀÇ ÇüÅÂÇÐÀû °üÂû

3Á¾ÀÇ donor cell·ÎºÎÅÍ °¢ 3Á¾ÀÇ iPS cell lineÀ» ±¸ÃàÇÏ¿´À¸¸ç, ÃÑ 9Á¾ÀÇ iPS cell line¿¡¼­ Sendai virus°¡ ÀÜÀçÇÏ°í ÀÖ´ÂÁö¸¦ È®ÀÎÇÏ¿´´Ù. °è´ë ¹è¾çÇÑ ¼¼Æ÷¿¡¼­ Real Time PCRÀ» ÀÌ¿ëÇØ Sendai virus RNA ¾çÀ» Á¤·®ÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. Passage 7-8¿¡¼­ 2/3ÀÇ iPS cell line¿¡¼­ Sendai virus RNA°¡ °ËÃâµÇÁö ¾Ê¾ÒÀ¸¸ç, Passage 11¿¡¼­´Â ¸ðµç iPS cell line¿¡¼­ Sendai virus RNA°¡ °ËÃâµÇÁö ¾Ê¾Ò´Ù. 36 cycle ÀÌÈÄ¿¡¼­ÀÇ Ct°ªÀº °ËÃâµÇÁö ¾ÊÀº °ÍÀ¸·Î ÆÇ´ÜÇÏ¿´´Ù (Ç¥ 2).

Passages 7-8

Passage 11

Number of negative iPS cell lines

6/9

9/9

Percent negative iPS cell lines

67

100

Ç¥ 2. Real Time PCRÀ» ÀÌ¿ëÇØ, ±¸ÃàµÈ iPS cell line¿¡¼­ÀÇ Sendai virus RNA È®ÀÎ

Passage 11ÀÇ iPS cell line¿¡¼­ stem cell markerÀÎ Oct4, SSEA-4, TRA-1-60, TRA-1-81¸¦ ¹ßÇöÇÏ°í ÀÖ´ÂÁö immunocytochemistry (ICC)·Î È®ÀÎÇÏ¿´´Ù. ´ëºÎºÐÀÇ ¼¼Æ÷¿¡¼­ 4Á¾ÀÇ stem cell marker¸¦ ¹ßÇöÇÏ¿´°í, negative markerÀÎ SSEA-1´Â ¹ßÇöÇÏÁö ¾Ê¾Ò´Ù. ÇÙ ¿°»öÀ» À§ÇØ DAPI¸¦ »ç¿ëÇÏ¿´´Ù. (±×¸² 3).


±×¸² 3. Immunocytochemistry (ICC)¸¦ ÀÌ¿ëÇÑ stem cell marker ¹ßÇö ºÐ¼®

[Âü°í ¹®Çå]
Asplund, A. et al. One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells. Stem Cell Rev. Reports 12, 90-104 (2016).    

Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-81 (2007).  

Schlaeger, T. M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58-63 (2015). 

Takahashi, K. et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131, 861-872 (2007).